{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:20:39Z","timestamp":1787566839373,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031663","name":"Saudi Food and Drug Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104062","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:50:42Z","timestamp":1784393442000},"page":"104062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pregnancy adverse events with immune checkpoint inhibitors in monotherapy and combination therapy in cancer: a disproportionality analysis"],"prefix":"10.1016","volume":"98","author":[{"given":"Eman A.","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf S.","family":"Alfadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basmah A.","family":"Albabtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneerah M.","family":"Aleissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-4470","authenticated-orcid":false,"given":"Ghadah H.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4077-4521","authenticated-orcid":false,"given":"Nada","family":"Alsuhebany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"De Vol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6710-933X","authenticated-orcid":false,"given":"Haifa","family":"Aldakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed M.","family":"Altowayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-2507","authenticated-orcid":false,"given":"Mohammed","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Y.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz F.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104062_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-020-0862-7","article-title":"Pregnancy and cancer: the INCIP project","volume":"22","author":"Maggen","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.eclinm.2026.104062_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.eclinm.2026.104062_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104062_bib5","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.3390\/ijms23158599","article-title":"Beyond cancer: regulation and function of PD-L1 in health and immune-related diseases","volume":"23","author":"Beenen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eclinm.2026.104062_bib6","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2026.104062_bib7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.26527","article-title":"Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma","volume":"97","author":"Evens","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.eclinm.2026.104062_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies","volume":"86","author":"Pentsuk","year":"2009","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.eclinm.2026.104062_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.eclinm.2026.104062_bib10","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.179.8.5211","article-title":"A link between PDL1 and T regulatory cells in fetomaternal tolerance","volume":"179","author":"Habicht","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2026.104062_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/cancers15010173","article-title":"Immune checkpoint inhibitors and pregnancy: analysis of the VigiBase\u00ae spontaneous reporting system","volume":"15","author":"Noseda","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.eclinm.2026.104062_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5625","article-title":"Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns","volume":"7","author":"Gougis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2026.104062_bib15","author":"Centre"},{"key":"10.1016\/j.eclinm.2026.104062_bib16","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.eclinm.2026.104062_bib17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/14740338.2020.1792883","article-title":"Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance","volume":"19","author":"Lee","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.eclinm.2026.104062_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bcp.13098","article-title":"The value of patient reporting to the pharmacovigilance system: a systematic review","volume":"83","author":"In\u00e1cio","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eclinm.2026.104062_bib19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s40264-018-0679-6","article-title":"Characteristics, quality and contribution to signal detection of spontaneous reports of adverse drug reactions via the WEB-RADR mobile application: a descriptive cross-sectional study","volume":"41","author":"Oosterhuis","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.eclinm.2026.104062_bib20","first-page":"1","article-title":"An investigation of the significance of residual confounding effect","volume":"2014","author":"Liang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.eclinm.2026.104062_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007409","article-title":"Corticosteroid-resistant immune-related adverse events: a systematic review","volume":"12","author":"Daetwyler","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.eclinm.2026.104062_bib22","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2026.104062_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CJI.0000000000000418","article-title":"Immune checkpoint inhibitor exposure in pregnancy: a scoping review","volume":"45","author":"Salehi","year":"2022","journal-title":"J Immunother"},{"key":"10.1016\/j.eclinm.2026.104062_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100262","article-title":"Immune checkpoint inhibitor administration during pregnancy: a case series","volume":"6","author":"Andrikopoulou","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.eclinm.2026.104062_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12850","article-title":"Placenta immune infiltrates and perinatal outcomes","volume":"79","author":"Ozen","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.eclinm.2026.104062_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1611","article-title":"Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis","volume":"3","author":"Chang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2026.104062_bib27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3389\/fphar.2019.01671","article-title":"Organ-specific immune-related adverse events associated with immune checkpoint inhibitor monotherapy versus combination therapy in cancer: a meta-analysis of randomized controlled trials","volume":"10","author":"Da","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104062_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272022","article-title":"Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy","volume":"17","author":"Cone","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2026.104062_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.eclinm.2026.104062_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/aji.12365","article-title":"Recent insight into the role of the PD-1\/PD-L1 pathway in feto-maternal tolerance and pregnancy","volume":"74","author":"Zhang","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.eclinm.2026.104062_bib31","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.1002031","article-title":"The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance","volume":"187","author":"D'Addio","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2026.104062_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:31:06Z","timestamp":1787560266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S2589537026003159"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104062","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy adverse events with immune checkpoint inhibitors in monotherapy and combination therapy in cancer: a disproportionality analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104062"}}